{"disease":{"id":"chronic-plaque-psoriasis","name":"chronic plaque psoriasis"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00799877","title":"Chronic Plaque Psoriasis (Ps) Registry","phase":"","overall_status":"COMPLETED","enrollment_count":6065,"lead_sponsor_name":"AbbVie","has_results":false},{"nct_id":"NCT03982394","title":"Observational Study of Patients With Moderate to Severe Chronic Plaque Psoriasis","phase":"","overall_status":"COMPLETED","enrollment_count":2759,"lead_sponsor_name":"AbbVie","has_results":false},{"nct_id":"NCT03598790","title":"A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1353,"lead_sponsor_name":"UCB Biopharma SRL","has_results":true},{"nct_id":"NCT05975268","title":"A Clinical Study to Evaluate the Efficacy and Safety of Subcutaneous JS005 Injection in the Treatment of Adults With Moderate to Severe Chronic Plaque Psoriasis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":747,"lead_sponsor_name":"Shanghai Junshi Bioscience Co., Ltd.","has_results":false},{"nct_id":"NCT03536884","title":"A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":743,"lead_sponsor_name":"UCB Biopharma SRL","has_results":true},{"nct_id":"NCT02074982","title":"Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":676,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT01640951","title":"4 Year Extension Study of Efficacy and Safety of Secukinumab in Patients With Moderate to Severe Chronic Plaque-type Psoriasis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":675,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT04785326","title":"Efficacy, Safety, and Immunogenicity of Subcutaneous DMB-3115 Versus Stelara® in Patients With Moderate to Severe Chronic Plaque Psoriasis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":598,"lead_sponsor_name":"Dong-A ST Co., Ltd.","has_results":true},{"nct_id":"NCT03370133","title":"A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Placebo and an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":567,"lead_sponsor_name":"UCB Biopharma SRL","has_results":true},{"nct_id":"NCT03412747","title":"A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":478,"lead_sponsor_name":"UCB Biopharma SRL","has_results":true},{"nct_id":"NCT04211389","title":"Twin Trial of PDE4 Inhibition With Roflumilast for the Management of Plaque Psoriasis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":442,"lead_sponsor_name":"Arcutis Biotherapeutics, Inc.","has_results":true},{"nct_id":"NCT04211363","title":"Trial of PDE4 Inhibition With Roflumilast for the Management of Plaque Psoriasis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":439,"lead_sponsor_name":"Arcutis Biotherapeutics, Inc.","has_results":true},{"nct_id":"NCT03410992","title":"A Study With a Initial Treatment Period Followed by a Randomized-withdrawal Period to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":435,"lead_sponsor_name":"UCB Biopharma SRL","has_results":true},{"nct_id":"NCT00233662","title":"Safety and Tolerability of Repeat Courses of IM Alefacept","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":400,"lead_sponsor_name":"Biogen","has_results":false},{"nct_id":"NCT05335356","title":"Comparing Efficacy and Safety of Bmab 1200 and Stelara in Patients With Moderate to Severe Chronic Plaque Psoriasis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":384,"lead_sponsor_name":"Biocon Biologics UK Ltd","has_results":true},{"nct_id":"NCT05637515","title":"Hulio Interchangeability to Humira®, Comparing Pharmacokinetics, Efficacy, Safety and Immunogenicity","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":374,"lead_sponsor_name":"Biocon Biologics Inc.","has_results":true},{"nct_id":"NCT05495568","title":"To Compare Pharmacokinetics, Efficacy, and Safety of CT-P17 With Humira in Patients With Moderate to Severe Chronic Plaque Psoriasis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":367,"lead_sponsor_name":"Celltrion","has_results":false},{"nct_id":"NCT04286607","title":"Open-Label Extension Trial of PDE4 Inhibition With Roflumilast for the Management of Plaque Psoriasis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":333,"lead_sponsor_name":"Arcutis Biotherapeutics, Inc.","has_results":false},{"nct_id":"NCT03504852","title":"Efficacy and Safety of 2 Secukinumab Regimens in 90kg or More Weight Group With Moderate/Severe Chronic Plaque Psoriasis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":331,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT03010527","title":"A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Patients With Chronic Plaque Psoriasis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":217,"lead_sponsor_name":"UCB Biopharma SRL","has_results":true},{"nct_id":"NCT03463187","title":"Multi-Dose Study of SHR-1314 in Subjects With Moderate-to-severe Plaque Psoriasis","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":211,"lead_sponsor_name":"Jiangsu HengRui Medicine Co., Ltd.","has_results":false},{"nct_id":"NCT06738277","title":"This is Comparative Study in Normal Healthy Subjects to Evaluate Pharmacokinetics, Safety, Tolerability of Bmab 1200 -Autoinjector (AI) After Single Subcutaneous Injection (45 mg) in Comparison With Bmab 1200 -Prefilled Syringe (PFS).","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":186,"lead_sponsor_name":"Biocon Biologics UK Ltd","has_results":false},{"nct_id":"NCT02570750","title":"The Effect Of Smoking Status Of The Patient On The Success Of Etanercept Therapy In Psoriasis","phase":"","overall_status":"COMPLETED","enrollment_count":183,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT03766685","title":"A Study to Evaluate the Safe and Effective Use of the Prefilled Safety Syringe or the Auto-injector for the Subcutaneous Self-injection of Bimekizumab Solution by Subjects With Moderate to Severe Chronic Plaque Psoriasis (PSO)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":172,"lead_sponsor_name":"UCB Biopharma SRL","has_results":true},{"nct_id":"NCT02471144","title":"Pediatric Study in Children and Adolescents With Severe Plaque Psoriasis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":162,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT03997786","title":"A Study of Tildrakizumab in Pediatric Subjects With Chronic Plaque Psoriasis","phase":"PHASE2, PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":135,"lead_sponsor_name":"Sun Pharmaceutical Industries Limited","has_results":false},{"nct_id":"NCT06011733","title":"A Study to Evaluate the Efficacy and Safety of Bimekizumab in Chinese Adult Study Participants With Moderate to Severe Plaque Psoriasis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":133,"lead_sponsor_name":"UCB Biopharma SRL","has_results":true},{"nct_id":"NCT02852967","title":"A Phase 2, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Belumosudil in Subjects With Moderate/Severe Chronic Plaque Psoriasis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":110,"lead_sponsor_name":"Kadmon Corporation, LLC","has_results":true},{"nct_id":"NCT07337434","title":"To Check Comparison of Apremilast and Methotrexate Efficacy in Patients With Moderate to Severe Plaque Psoriasis Presented to Tertiary Care Hospital","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":106,"lead_sponsor_name":"Syeda Sana Zaman","has_results":false},{"nct_id":"NCT06591273","title":"Efficacy and Safety of Infliximab Biosimilar in Treatment of Moderate to Severe Psoriasis; A Single-arm Clinical Trial","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":104,"lead_sponsor_name":"Services Institute of Medical Sciences, Pakistan","has_results":false},{"nct_id":"NCT03897075","title":"Efficacy and Safety Study of Tildrakizumab in the Treatment of Nail Psoriasis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":99,"lead_sponsor_name":"Sun Pharmaceutical Industries Limited","has_results":true},{"nct_id":"NCT02690701","title":"Study to Evaluate the Effect of Secukinumab Compared to Placebo on Aortic Vascular Inflammation in Subjects With Moderate to Severe Plaque Psoriasis","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":91,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT04207801","title":"A Phase II Study to Evaluate Efficacy & Safety of AUR101 in Patients of Moderate-to-Severe Psoriasis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":90,"lead_sponsor_name":"Aurigene Discovery Technologies Limited","has_results":true},{"nct_id":"NCT03668613","title":"Study to Assess the Long-term Safety, Tolerability, Efficacy of Secukinumab in Pediatric Patients of Age 6 to <18 Years, With Moderate to Severe Plaque Psoriasis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":84,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT00770965","title":"Phase II Efficacy Study Looking at a Single-dose of One of Three Dose Levels of AIN457 in Patients With Chronic Plaque-type Psoriasis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT03858634","title":"A Study to Assess the Efficacy, Safety, and Tolerability of KPL-716 in Reducing Pruritus in Chronic Pruritic Diseases","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":58,"lead_sponsor_name":"Genentech, Inc.","has_results":true},{"nct_id":"NCT04123795","title":"A Study to Evaluate the Pharmacokinetics, Safety, and Effectiveness of Certolizumab Pegol in Children With Moderate to Severe Chronic Plaque Psoriasis","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":49,"lead_sponsor_name":"UCB Biopharma SRL","has_results":false},{"nct_id":"NCT03025542","title":"A Study to Evaluate the Pharmacokinetics (PK), Pharmacodynamics (PD), and Safety of Bimekizumab in Patients With Chronic Plaque Psoriasis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":49,"lead_sponsor_name":"UCB Biopharma SRL","has_results":true},{"nct_id":"NCT03023254","title":"An Exploratory Study to Assess the Efficacy of the Avène Hydrotherapy","phase":"NA","overall_status":"COMPLETED","enrollment_count":44,"lead_sponsor_name":"Pierre Fabre Dermo Cosmetique","has_results":false},{"nct_id":"NCT03230292","title":"A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Adult Patients With Chronic Plaque Psoriasis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":43,"lead_sponsor_name":"UCB Biopharma SRL","has_results":true},{"nct_id":"NCT05388916","title":"A Real-world Study to Assess Safety and Effectiveness of Secukinumab in Pediatric Plaque Psoriasis Patients in China","phase":"","overall_status":"COMPLETED","enrollment_count":42,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT03553823","title":"Comparison of Secukinumab Versus Guselkumab in Clearing Psoriatic Plaques Refractory to Ustekinumab","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT00419666","title":"A Study of Calcitriol BID Topical Treatment in Adolescents With Plaque Psoriasis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"Galderma R&D","has_results":true},{"nct_id":"NCT04221906","title":"Study to Evaluate the Safety and Antipsoriatic Efficacy of BOS-475 in a Psoriasis Plaque Test","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Boston Pharmaceuticals","has_results":false}],"total":44},"guidelines":[{"drug_id":"abrilada","guideline_body":"FDA label","recommendation":"Treatment of adult patients with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy, and when other systemic therapies are medically less appropriate.","line_of_therapy":"1L|2L","evidence_grade":"not specified","guideline_year":null}],"source":"Drug Landscape verified database"}